BioSpace News Archive

GC Genome is pleased to announce that the company presented the deep learning algorithm that detects and classifies multi-cancer using cf-WGS, summarized in a poster session held at the American Association for Cancer Research Annual Meeting 2022 in New Orleans, Louisiana.

On April 15th, SonoScape announced that the U.S. Food and Drug Administration has approved its flagship video endoscopy system HD-550 for gastrointestinal diagnosis, setting up a major milestone on SonoScape’s Endoscopic product roadmap.

BeiGene, Ltd. announced that the China National Medical Products Administration has granted approval to BeiGene’s anti-PD-1 antibody, tislelizumab, as a treatment for patients with locally advanced or metastatic esophageal squamous cell carcinoma who have disease progression or are intolerant to first-line standard chemotherapy.

Click Therapeutics, Inc. today announced that it has secured a $15 million term loan from Silicon Valley Bank.

Palantir Technologies Inc. (NYSE:PLTR) today announced an extension and expansion of its work with the U.S. Centers for Disease Control and Prevention (CDC) through the outbreak response and disease surveillance solution for the Data Collation and Integration for Public Health Event Response (DCIPHER) Program.

HRH is Only Hospital in Hudson County with Any SRC Accreditation.

Company to host conference call, Monday, April 18, 2022 at 8:30 AM ET.

Salt Lake City’s premier center for scoliosis rehabilitation utilizes custom-made, over-corrective braces designed to treat scoliosis and postural deformities at their root.

MaxCyte, Inc. today announced that, on April 11, 2022, the Compensation Committee of MaxCyte’s Board of Directors granted stock options to purchase (i) an aggregate of 54,000 share.

Catalent today announced that it will release financial results for the third quarter of fiscal year 2022 ended March 31, 2022, before the market open on Tuesday, May 3, 2022.